chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 46.0
Sex: M
Vaccine: COVID19
Symptoms: Axillary mass, Axillary pain
Clinical narrative: I have a lump under my arm and hurts a little looks a swell; I have a lump under my arm and hurts a little; This is a spontaneous report from a contactable consumer, the patient. A 46-year-old male patient received unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 14Apr2021 at 11:15 (at the age of 46-year-old) as a single dose for COVID-19 immunisation. Medical history included allergy to penicillin. The patient previously took tetanus vaccine (MANUFACTURER UNKNOWN) on 09Apr2021. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications were not reported. On 14Apr2021 at 16:15, the patient experienced a lump under arm which was hurting a little and looked like a swell. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event of lump under arm which was hurting a little and looked like a swell was unknown at the time of this report.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Ocular hyperaemia, Swelling of eyelid
Clinical narrative: Swollen eye lid; Red eye; This is a spontaneous report from a contactable consumer, the patient. A 36-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: EP7533) via an unspecified route of administration in the left arm on 14Apr2021 at 11:45 (at the age of 36-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medication were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: EP6955) via an unspecified route of administration in the left arm on 24Mar2021 at 11:45 (at the age of 36-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. Since the vaccination, the patient had not been tested for COVID-19. On 14Apr2021 at 16:00, the patient experienced swollen eye lid and red eye. The events resulted in doctor or other healthcare professional office/clinic visit. Unspecified therapeutic measures were taken as a result of the events. The clinical outcome of the events swollen eye lid and red eye were resolving at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Illness, Pain, Pyrexia, Vomiting
Clinical narrative: Dizziness; Ache all over; Fever; Sick to point of vomiting; Sick to point of vomiting; This is a spontaneous report from a contactable consumer, the patient. An 83-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6207) via an unspecified route of administration in the arm left on 19Mar2021 at 13:00 (at the age of 83-year-old) and second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EB8733) via an unspecified route of administration in the arm left on 14Apr2021 (at the age of 83-year-old) as a single dose for COVID-19 immunisation. Medical history included sulfonamide allergy (all sulphur drugs) and COVID-19. Prior to the vaccination, the patient was diagnosed with COVID-19. The patient did not receive any other medicines within two weeks prior to the COVID-19 vaccine. The patient did not receive any other vaccines within four weeks prior to the vaccination. Since the vaccination, the patient had been tested for COVID-19. On 19Mar2021 at 15:30, on the first vaccine, the patient experienced dizziness, ache all over, fever, sick to point of vomiting. This lasted three and half days. Exact same reaction to second shot but only one and half days. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. On an unknown date post vaccination, the patient underwent COVID-19 nasal swab test and the result was negative. The clinical outcome of the events dizziness, ache all over, fever, sick to point of vomiting were recovered on an unknown date in 2021.  No follow-up attempts are needed. No further information is expected.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Pain, Pyrexia
Clinical narrative: This is a spontaneous report from a contactable consumer or other non-HCP (patient). A 42-year-old (non-pregnant) female patient received the 2nd dose of BNT162B2 (Pfizer-BioNTech COVID-19 vaccine, formulation solution for injection, batch/lot# EW0151), age at vaccination of 42, via an unspecified route of administration, right arm, single dose, on Apr 15, 2021, at 11:15 am; and dose 1, (batch/lot# ER8732), on Mar 25, 2021, at 11:45 am, single dose, for COVID-19 immunization. The patient's medical history and concomitant medications not reported. Reportedly, no COVID-19 prior vaccination. The patient has not tested for COVID-19 post vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. Prior to vaccination, patient was not diagnosed with COVID-19. Since the vaccination, patient has not tested for COVID-19. Facility where the most recent COVID-19 vaccine was administered: Doctor's office/urgent care. On Apr 15, 2021, at 11:30 pm, patient experienced 102 fever, chills and body aches. Therapeutic measures were taken with Advil, as a result of the adverse events. The clinical outcome of the events: not recovered. No follow-up attempts needed. No further information expected.
Age: 28.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Vaccination site pain
Clinical narrative: Soreness at injection site; Moderate to severe fatigue for 2 days; This is a spontaneous report from a non-contactable consumer, the patient. A 28-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6200) via an unspecified route of administration in the arm left on 10Apr2021 at 10:30 (at the age of 28-year-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Concomitant medications included THRIVE by Le-Vel Dietary Supplements for unknown indication from an unknown date. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6202) via an unspecified route of administration in the arm left on 13Mar2021 at 10:30 (at the age of 28-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 10Apr2021 at 13:00, the patient experienced soreness at injection site and moderate to severe fatigue for 2 days. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the event soreness at injection site and moderate to severe fatigue for 2 days was resolved on an unspecified date in Apr2021.  No follow-up attempts are possible. No further information is expected.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Contusion, Influenza like illness, Lymph node pain, Pain, Pain in extremity
Clinical narrative: Flu like symptoms; All over body aches; bruising like pain on the arm of the injection; bruising like pain on the arm of the injection; Fever that lasted approximately 10 hours; soreness around lymph nodes; This is a spontaneous report from a contactable consumer, the patient. A 37-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0153) via an unspecified route of administration in the left arm on 14Apr2021 at 18:45 (at the age of 37-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history. The patient did not receive any other medications within two weeks of vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8723) via an unspecified route of administration in the left arm on 24Mar2021 at 18:45 (at the age of 37-years-old) as a single dose for COVID-19 immunisation. The patient previously received amoxicillin (MANUFACTURER UNKNOWN) for an unknown indication on an unknown date and experienced allergy. Prior to vaccination, patient was not diagnosed with COVID-19; Since the vaccination, patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 15Apr2021 at 16:00, the patient experienced flu like symptoms about 22 hours after vaccination, all over body aches and bruising like pain on the arm of the injection, fever that lasted approximately 10 hours and soreness around lymph nodes. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the reported events. The clinical outcome of the events flu like symptoms about 22 hours after vaccination, all over body aches and bruising like pain on the arm of the injection, and soreness around lymph nodes was recovered on an unknown date in Apr2021 while the event fever that lasted approximately 10 hours was recovered on 16Apr2021 at 02:00.  No follow-up attempts are needed. No further information is expected.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Flu like symptoms; All over body aches; bruising like pain on the arm of the injection; bruising like pain on the arm of the injection; Fever that lasted approximately 10 hours; soreness around lymph nodes; This is a spontaneous report from a contactable consumer, the patient. A 37-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0153) via an unspecified route of administration in the left arm on 14Apr2021 at 18:45 (at the age of 37-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history. The patient did not receive any other medications within two weeks of vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8723) via an unspecified route of administration in the left arm on 24Mar2021 at 18:45 (at the age of 37-years-old) as a single dose for COVID-19 immunisation. The patient previously received amoxicillin (MANUFACTURER UNKNOWN) for an unknown indication on an unknown date and experienced allergy. Prior to vaccination, patient was not diagnosed with COVID-19; Since the vaccination, patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 15Apr2021 at 16:00, the patient experienced flu like symptoms about 22 hours after vaccination, all over body aches and bruising like pain on the arm of the injection, fever that lasted approximately 10 hours and soreness around lymph nodes. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the reported events. The clinical outcome of the events flu like symptoms about 22 hours after vaccination, all over body aches and bruising like pain on the arm of the injection, and soreness around lymph nodes was recovered on an unknown date in Apr2021 while the event fever that lasted approximately 10 hours was recovered on 16Apr2021 at 02:00.  No follow-up attempts are needed. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Headache
Clinical narrative: Headache; achy joints; This is a spontaneous report from a contactable consumer, the patient. A non-pregnant female patient of an unknown age received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 15Apr2021 at 11:30 as a single dose for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 24Mar2021 (at the age of 47 years old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 16Apr2021, the patient experienced headache and achy joints. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the reported event. The clinical outcome of the events headache and achy joints was not resolved.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling abnormal
Clinical narrative: It feels like looking out of a train sitting in a forward position. So not looking in the reverse.; This is a spontaneous report from a contactable healthcare professional, nurse. A 44-year-old non-pregnant female patient received a second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6201) via an unspecified route of administration in left arm on 04Mar2021 at 15:15 (at the age of 44-years-old). as a single dose for COVID-19 immunisation. The patient's medical history included allergy to penicillin. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient's concomitant medications included montelukast sodium (MONTELUKAST), azelastine (MANUFACTURER UNKNOWN), fluticasone (MANUFACTURER UNKNOWN) and olopatadine (MANUFACTURER UNKNOWN) for unknown indications from an unknown duration. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6201) via an unspecified route of administration in left arm on 11Feb2021 at 17:00, as a single dose for COVID-19 immunisation. On 05Mar2021 at 07:00, the patient had felt like she was looking out of a train sitting in a forward position, so not looking in the reverse. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit and emergency room/department or urgent care. No therapeutic measures were taken as a result of adverse events. The clinical outcome of the event, felt like she was looking out of a train sitting in a forward position, so not looking in the reverse was not recovered at the time of report.   No follow-up attempts are needed. No further information is expected.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Dysgeusia, Dysphagia, Paraesthesia oral, Swollen tongue
Clinical narrative: This is a spontaneous report from a contactable consumer (patient). A 45-year-old (non-pregnant) female patient received the first dose of BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine; batch/lot# unknown), at the age of 45, via an unspecified route of administration, right arm, on Apr 14, 2021, at 14:45, single dose, for COVID-19 immunisation. The patient has not reported any other health issues. The patient has no known allergies to medications, food or other products. Prior to the vaccination, patient was not diagnosed with COVID-19. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. Concomitant medications included omeprazole and Biotin; both from an unknown date for unknown indication. On Apr 14, 2021, at 14:45, patient's tongue felt like it was swollen-up, unable to swallow, metallic/medicine-like taste and tingling lips. It lasted about 8 minutes, then got a little better but still hard to swallow and lips were tingling for a few hours. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures taken as a result of reported events included treatment with OTC Benadryl (diphenhydramine). Since the vaccination, patient has not tested for COVID-19. The outcome of tongue felt like it was swollen-up, unable to swallow, metallic/medicine-like taste and tingling lips recovered on an unknown date in Apr 2021. No follow-up attempts needed. Information about lot/batch number cannot be obtained.
Age: 21.0
Sex: F
Vaccine: COVID19
Symptoms: Chest pain, Fatigue, Pain, Vomiting
Clinical narrative: Severe Chest Pain; Body aches; Vomiting; Fatigue; This is a spontaneous report from a contactable consumer. A 21-years-old non-pregnant female patient received BNT162b2 (PFIZER BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot number and Expiration date was not reported), via an unspecified route of administration, administered in left arm on 15Apr2021 at 12:00 hours as dose 1, single (at the age of 21-years-old) for COVID-19 immunisation. Patient had no medical history and no known allergies. The patient's concomitant medications were not reported. Patient had no other vaccine in four weeks. Patient was not diagnosed with COVID-19, prior to vaccination and had not been tested for COVID-19, post vaccination. On 15Apr2021 at 23:45 hours, patient experienced severe chest pain, body aches, vomiting and fatigue. Patient received no treatment for the events. The outcome of all the events was not recovered.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 39.0
Sex: M
Vaccine: COVID19
Symptoms: Cold urticaria
Clinical narrative: Cold urticaria: getting hives, redness and swelling to skin exposed to cold; This is a spontaneous report from a contactable consumer, the patient. A 39-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8733) via an unspecified route of administration in the left arm on 31Mar2021 at 10:30 (at the age of 39-years-old) as a single dose for COVID-19 immunisation. Other medical history was reported as none. The patient had known allergies to pethidine hydrochloride (DEMEROL). Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any medications within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 09Apr2021 at 18:15, the patient experienced cold urticaria: patient got hives, redness and swelling to skin exposed to cold. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event cold urticaria was not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Malaise, Myalgia, Oropharyngeal pain
Clinical narrative: I am feeling sick (throat pain, muscle ache, shivering etc); I am feeling sick (throat pain, muscle ache, shivering etc); I am feeling sick (throat pain, muscle ache, shivering etc); I am feeling sick (throat pain, muscle ache, shivering etc); This is a spontaneous report from a non-contactable consumer, the patient. A 45-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 30Mar2021 at 12:00 (at the age of 45-year-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient did not receive any other medicines within two weeks prior to the COVID-19 vaccine. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 10Apr2021, the patient was feeling sick (throat pain, muscle ache, shivering etc). Everyone including the patient from their household at home only and working remotely. The patient enquired regarding what were the possibilities to get symptoms like this after first dose. Should these side effects of vaccine last even after 15 days? Should she worry about these symptoms? After first dose of vaccine if someone gets COVID do they experience these kinds of symptoms? If someone got attacked by COVID right before first dose of vaccine, do they experience these kinds of symptoms? What if someone got vaccinations and not aware of having COVID did they experience these kinds of symptoms? Therapeutic measures were not taken as a result of the events. The clinical outcome of the events feeling sick (throat pain, muscle ache, shivering etc) were not recovered at the time of this report.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Herpes zoster
Clinical narrative: Shingles on right side, mid back to front and upper right leg; This is a spontaneous report from a contactable consumer, the patient. A 70-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 30Mar2021 at 13:00 (at the age of 70-year-old) as a single dose for COVID-19 immunisation. Medical history included double vessel bypass graft (double by-pass 4 years ago) in 2017 and peanut allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Two days after getting first Pfizer shot, on 01Apr2021, the patient developed shingles on right side, mid back to front and upper right leg. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of event with antiviral medications. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event shingles on right side, mid back to front and upper right leg was resolving at the time of this report.   No follow-up attempts are possible; information about lot number cannot be obtained. No further information is expected.
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Headache, Photophobia
Clinical narrative: Headaches; Light sensitivity; Dizziness; This is a spontaneous report from a contactable consumer, the patient. A 29-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0150) via an unspecified route of administration in the left arm on 07Apr2021 at 14:15 (at the age of 29-year-old) as a single dose for COVID-19 immunisation. Medical history included illness, the patient developed a strange illness a few years ago, suffered health concerns since and penicillin allergy. The patient did not receive any other medicines within two weeks prior to the COVID-19 vaccine. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 07Apr2021 at 16:00, the patient experienced headaches, also had some light sensitivity and dizziness. It had been over a week and the patient continued to have headaches. It does not seem like the headaches were stopping. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events headaches, light sensitivity and dizziness were not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Mobility decreased, Pyrexia
Clinical narrative: This is a spontaneous report from a contactable consumer. A 47-year-old female patient received unknown dose number of BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine, solution for injection, batch/lot# not reported), via an unspecified route of administration, on an unspecified date, single dose, for COVID-19 immunisation. The patient's medical history included non-smoker. Concomitant medications not reported. On unspecified date, patient experienced 100.8 fever, chills and can't hard move the arm she got the shot in; with outcome of unknown. The patient is  perfectly healthy. The reporter asked about concomitant use with Viagra (sildenafil citrate) and about alcohol consumption. Information about lot/batch number cannot be obtained. No further information expected.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling hot, Induration, Pain in extremity, Pyrexia, Vaccination site erythema
Clinical narrative: fever; a lot of pain from her knees and below/really painful from her elbow down; swelling and redness of the injection site; swelling and redness of the injection site; it's hard and warm; it's hard and warm; This is a spontaneous report from a contactable consumer (patient). A 60-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot number was not reported), dose 1 via an unspecified route of administration on 13Apr2021 (at the age of 60-year-old) as dose 1, single for COVID-19 immunization. The patient medical history and concomitant medications were not reported. Patient stated that she received her first dose of the Pfizer Covid-19 vaccine on Tuesday (13Apr2021) and after 24 hours she presented fever, a lot of pain from her knees and below (Apr2021). After 27 hours she presented swelling and redness of the injection site. She stated that it was really painful from her elbow down, "it's hard and warm" (Apr2021). She would like to know it was normal because she had no insurance. The clinical outcome of events was unknown.  No follow-up attempts are needed. information about lot/batch number cannot be obtained.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site swelling
Clinical narrative: fever; a lot of pain from her knees and below/really painful from her elbow down; swelling and redness of the injection site; swelling and redness of the injection site; it's hard and warm; it's hard and warm; This is a spontaneous report from a contactable consumer (patient). A 60-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot number was not reported), dose 1 via an unspecified route of administration on 13Apr2021 (at the age of 60-year-old) as dose 1, single for COVID-19 immunization. The patient medical history and concomitant medications were not reported. Patient stated that she received her first dose of the Pfizer Covid-19 vaccine on Tuesday (13Apr2021) and after 24 hours she presented fever, a lot of pain from her knees and below (Apr2021). After 27 hours she presented swelling and redness of the injection site. She stated that it was really painful from her elbow down, "it's hard and warm" (Apr2021). She would like to know it was normal because she had no insurance. The clinical outcome of events was unknown.  No follow-up attempts are needed. information about lot/batch number cannot be obtained.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling hot, Pruritus
Clinical narrative: started feeling kinda itchy; hot all over; This is a spontaneous report from a contactable consumer, the patient. A 46-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: unknown) via an unspecified route of administration on 13Apr2021 at 12:30 (at the age of 46-year-old) as a single dose for COVID-19 immunisation. Medical history included blood pressure high. Concomitant medications included triamterene (MANUFACTURER UNKNOWN) taken for unknown indication on unknown date. The patient had no known drug allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 13Apr2021 at 17:30, after 5 hours of getting the vaccine, the patient experienced feeling kinda itchy and hot all over. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of events and included treatment with benadryl (MANUFACTURER UNKNOWN) from unknown start date to an unknown stop date which helped the patient but 3 days later she is still dealing with the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events itchy and hot all over was recovering at the time of this report.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 18.0
Sex: F
Vaccine: COVID19
Symptoms: Cognitive disorder, Confusional state, Muscle contractions involuntary, Somnolence
Clinical narrative: Short (1-3 second) muscle contractions in opposite shoulder of injection site and in opposite posterior muscle (near the scapula); Drowsiness; Confusion; unclear cognitive function; This is a spontaneous report from a contactable consumer, the patient. An 18-year-old non-pregnant female patient received an unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8729) via an unspecified route of administration on 15Apr2021 at 17:15 (at the age of 18-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, it was unknown whether the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On an unknown date in Apr2021, the patient experienced short (1-3 second) muscle contractions in the opposite shoulder of injection site and short contractions in the opposite posterior muscle (near the scapula); the patient also experienced some drowsiness and confusion (unclear cognitive function). Therapeutic measures were not taken as a result of the events. The clinical outcome of the events short muscle contractions in the opposite shoulder of injection site and in the opposite posterior muscle (near the scapula), drowsiness and confusion (unclear cognitive function) were unknown at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Rash morbilliform
Clinical narrative: Morbilliform rash developed on torso and back; This is a spontaneous report from a contactable consumer, the patient. A 33-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8729) via an unspecified route of administration in the left arm on 14Apr2021 at 14:30 (at the age of 33-years-old) as a single dose for COVID-19 immunisation.  Medical history of the patient was not reported. The patient had no known allergies.  Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6207) via an unspecified route of administration in the left arm on 24Mar2021 at 16:00 (at the age of 33-years-old) as a single dose for COVID-19 immunisation. Concomitant medications included escitalopram oxalate (LEXAPRO) and fexofenadine hydrochloride (ALLEGRA) both from unknown dates for unknown indications and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 16Apr2021 at 10:00, the patient experienced morbilliform rash developed on torso and back. The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as the result of adverse events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event morbilliform rash developed on torso and back was not recovered at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Pruritus
Clinical narrative: Hands and face turned red; Hands and face itchy; This is a spontaneous report from a contactable consumer, the patient. A 49-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EW0161) via an unspecified route of administration in the left arm on 15Apr2021 at 13:30 (at the age of 49-year-old) as a single dose for COVID-19 immunisation. The patient had no medical history. The patient had no allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any medications within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 16Apr2021 at 13:30, 24 hours after injection, the patient's hands and face turned red and itchy. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of the events which included treatment with BENADRYL every (q) 6 hours which was prescribed when the patient called the doctor. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events hands and face turned red and hands and face itchy were recovering at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 45.0
Sex: M
Vaccine: COVID19
Symptoms: Eye pruritus, Lacrimation increased, Photophobia
Clinical narrative: Eyes itching; Light sensitivity; Eyes water; This is a spontaneous report from a contactable consumer, the patient. A 45-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8737) via an unspecified route of administration in the left arm on 16Apr2021 at 15:30 (at the age of 45-year-old) as a single dose for COVID-19 immunisation. Medical history included blood pressure high. The patient is allergic to bees and has been admitted in the hospital multiple times because of bee stings which caused throat swelling and eyes itch. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications were not reported. On 16Apr2021 at 16:15 after about 30 minutes from getting the first dose of the vaccine, the patient eyes started itching, eyes water and had light sensitivity. It immediately took him back to being a 12-year-old and being stung by a bee. He had been sitting in the dark for about 20 minutes. It had been over 30 years since he had this feeling. He did not know if he was just weird but he thought he should pass the message along. Therapeutic measures were not taken as a result of the events. The events did not result in doctor or other healthcare professional office or clinic visit, and emergency room or department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events eyes started itching, light sensitivity and eyes water was not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Parosmia, Skin tightness, Taste disorder
Clinical narrative: Facial tightening right side (already have Ramsay Hunt Syndrome); Altered taste; Altered sense of smell; This is a spontaneous report from a contactable consumer, the patient. A 35-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8733) via an unspecified route of administration in the right arm on 06Apr2021 at 11:15 (at the age of 35-years-old) as a single dose for COVID-19 immunisation. Medical history included Ramsay-hunt syndrome which was still ongoing and post herpetic neuralgia.   Prior to the vaccination, the patient was diagnosed with COVID-19. The patient previously took cefaclor (CECLOR) on an unknown date for an unknown indication and experienced drug allergy. Concomitant medications included quetiapine fumarate (SEROQUEL), pregabalin (LYRICA), fluticasone propionate (FLONASE), fexofenadine hydrochloride (ALLEGRA) and paracetamol (TYLENOL); all from unknown dates for unknown indications and unknown if ongoing.  The patient did not receive any other vaccines within four weeks prior to the vaccination. On 09Apr2021, the patient experienced facial tightening right side (already have Ramsay Hunt Syndrome) , altered taste and altered sense of smell. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events of facial tightening right side, altered taste and altered sense of smell were not resolved at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Rash erythematous, Rash pruritic, Rash vesicular
Clinical narrative: Itchy rash; blistered rash; Rash in multiple forms--red, raised,very itchy,; This is a spontaneous report from a contactable consumer, the patient. A 71-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL9262) via an unspecified route of administration in the left arm on 30Jan2021 at 17:30 (at the age of 71-years-old) as a single dose for COVID-19 immunisation. The patient did not have any medical history. Patient had no allergy to food, medication or other products. Concomitant medications included ibuprofen sodium (IBUPROFEN), vitamin d (VIT D), tocopherols mixed, tocotrienols nos (VITAMIN E), melatonin (MELATONINE) and magnesium (MANUFACTURER UNKNOWN); all for unspecified indication and from unknown start date. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 31Jan2021 at 13:00, the patient experienced rash in multiple forms, red, raised, very itchy, 1/4 to 1/2 inch in diameter, some were blistered, some turned purple and some that were pink, some red. The rash was appeared over forearms and legs and additionally there was a different kind presentation with an abdominal rash that was very concentrated with tiny dots. It lasted 3 weeks with new itchy spots were showing up over about 2 weeks. The event resulted in emergency room/department or urgent care. Therapeutic measures were taken as a result of event and included treatment with antihistamines(unspecified) and cortisone cream from an unknown start date to an unknown stop date. The clinical outcomes of the event itchy rash, red rash and blistery rash were recovered on an unknown date in 2021. The patient also received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Unknown) via an unspecified route of administration on an unknown date in 2021 as a single dose for COVID-19 immunisation.  No follow-up attempts are needed. No further information is expected.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Fatigue, Headache
Clinical narrative: episodes of dizziness; fatigue; moderate headaches; This is a spontaneous report from a contactable consumer, the patient. A 46-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6204) via an unspecified route of administration in the left arm on 12Apr2021 at 14:00 (at the age of 46-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient received iron supplements within two weeks of vaccination from an unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6202) via an unspecified route of administration in the left arm on 22Mar2021 at 14:00 (at the age of 46-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. It was unknown whether the patient received any other vaccines within four weeks prior to the vaccination. On 15Apr2021 at 12:00, the patient experienced episodes of dizziness which lasts about 2 -5 minutes. Her body was still fatigue and had moderate headaches. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. The clinical outcome of the events episodes of dizziness, fatigue and moderate headaches were not recovered at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 25.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, Hypoaesthesia, Nausea
Clinical narrative: Left hand and left forearm became numb; Light-headedness; Nausea; This is a spontaneous report from a contactable consumer, the patient. A 25-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8729) via an unspecified route of administration in the left arm on 14Apr2021 at 10:00 (at the age of 25-years-old) as a single dose for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 15Apr2021 at 17:15, the patient's left hand and left forearm became numb, followed by light-headedness and nausea. The events did not result in doctor or other healthcare professional office/clinic visit/ emergency visit. No therapeutic measures were taken as a result of the reported adverse events. The clinical outcome of the events left hand and left forearm became numb, light-headedness and nausea was resolved on an unknown date in Apr2021.  No follow-up attempts are needed. No further information is expected.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Herpes zoster
Clinical narrative: diagnosed with shingles.; This is a spontaneous report from a contactable consumer, the patient. A 59-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6202) via an unspecified route of administration in the left arm on 02Mar2021 at 14:45 (at the age of 59-year-old) as a single dose for COVID-19 immunisation. Medical history included mild hypertension, moderate high cholesterol, asthma, sulfa drugs allergy, penicillin allergy and fruit allergy (reported as citrus and tropical fruits). The patient received other medications (unspecified) within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 26Mar2021, the patient diagnosed with shingles within 26 days of vaccination. The event resulted in emergency room/department or urgent care. Therapeutic measures were taken as a result of shingles and included treatment with unspecified antiviral medication and antibiotics from an unknown date. The clinical outcome of the event shingles within 26 days of vaccination was resolved on an unknown date in the year 2021.   No follow-up attempts are needed. No further information is expected.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Pain in extremity, Pyrexia
Clinical narrative: Fever; Diarrhoea; Pain in my arm; This is a spontaneous report from a contactable consumer (patient) via Medical information team. A 42-year-old female patient received first dose of bnt162b2 (BNT162B2, Solution for injection, Lot number was not reported), via an unspecified route of administration, administered in Arm Right on 14Apr2021 as DOSE 1, SINGLE for covid-19 immunisation. Medical history included covid-19 from an unknown date and unknown if ongoing (She was COVID positive before the vaccine). The patient concomitant medications were not reported. On the 14Apr2021 patient got the vaccine and patient had fever and diarrhea and pain in her arm on 15Apr2021. Patient have already filed a report. Since patient got this reaction with the first dose is it recommended to get the second dose on May 5th? All her symptoms are gone except for the pain in her arm. The outcome of the events fever and diarrhoea was recovered on 15Apr2021 and pain in arm was not recovered.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 50.0
Sex: M
Vaccine: COVID19
Symptoms: Decreased appetite, Fatigue, Headache, Pain, Pyrexia
Clinical narrative: This is a spontaneous report from a contactable consumer (patient). A 50-year-old male patient received the first dose of BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine; batch/lot# ER8731), at the age of 50, via an unspecified route of administration, left arm, on Apr 9, 2021, at 14:00, single dose, for COVID-19 immunisation. Other medical history reported as none. The patient has no known allergies to medications, food or other products. Prior to the vaccination, patient was not diagnosed with COVID-19. The patient did not receive any medications within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. On Apr 10, 2021, at 12:00, patient experienced all the typical side effects of the vaccine, including fatigue, aches, headaches, fever and appetite loss. Instead of lasting 2-3 days, this lasted a whole week and hasn't gone away completely at the time of this report. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were not taken as a result of the events. Since the vaccination, patient has not tested for COVID-19. The clinical outcome of aches, appetite loss, fatigue, headache and fever: not recovered (at the time of this report). No follow-up attempts needed. No further information expected.